Požymis
Abnormal heart rate
Klinikinis pavadinimas: Arrhythmia
Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both.
Santrauka
- Taip pat vadinama
- Heart rhythm disorders, Irregular heart beat, Irregular heartbeat, Arrhythmias, Cardiac arrhythmia, Cardiac arrhythmias, Cardiac rhythm disturbances
- Kūno sistema
- Abnormality of the cardiovascular system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Abnormal heart rate, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test239 genų susiję su Abnormal heart rate
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Abnormal heart rate. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CRELD1CRELD disulfide isomerase 1 | Visada | 1 ligoje |
| JKAMPJNK1/MAPK8 associated membrane protein | Visada | 1 ligoje |
| LMNAlamin A/C | Visada | 5 ligose |
| OAS22'-5'-oligoadenylate synthetase 2 | Visada | 1 ligoje |
| TOP3ADNA topoisomerase III alpha | Visada | 1 ligoje |
| TTNtitin | Visada | 2 ligose |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Labai dažnai (80–99%) | 2 ligose |
| ELNelastin | Labai dažnai (80–99%) | 1 ligoje |
| GPX4glutathione peroxidase 4 | Labai dažnai (80–99%) | 2 ligose |
| JUPjunction plakoglobin | Labai dažnai (80–99%) | 1 ligoje |
| NKX2-5NK2 homeobox 5 | Labai dažnai (80–99%) | 3 ligose |
| PHOX2Bpaired like homeobox 2B | Labai dažnai (80–99%) | 1 ligoje |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Labai dažnai (80–99%) | 2 ligose |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Labai dažnai (80–99%) | 4 ligose |
| SCNN1Asodium channel epithelial 1 subunit alpha | Labai dažnai (80–99%) | 2 ligose |
| SCNN1Bsodium channel epithelial 1 subunit beta | Labai dažnai (80–99%) | 2 ligose |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Labai dažnai (80–99%) | 2 ligose |
| SLC25A20solute carrier family 25 member 20 | Labai dažnai (80–99%) | 1 ligoje |
| TSPYL1TSPY like 1 | Labai dažnai (80–99%) | 1 ligoje |
| ABCC9ATP binding cassette subfamily C member 9 | Dažnai (30–79%) | 1 ligoje |
| ACTC1actin alpha cardiac muscle 1 | Dažnai (30–79%) | 2 ligose |
| ACTN2actinin alpha 2 | Dažnai (30–79%) | 1 ligoje |
| ANKRD1ankyrin repeat domain 1 | Dažnai (30–79%) | 1 ligoje |
| ATP5F1AATP synthase F1 subunit alpha | Dažnai (30–79%) | 1 ligoje |
| ATP5F1DATP synthase F1 subunit delta | Dažnai (30–79%) | 1 ligoje |
| ATP5F1EATP synthase F1 subunit epsilon | Dažnai (30–79%) | 1 ligoje |
| ATP5MKATP synthase membrane subunit k | Dažnai (30–79%) | 1 ligoje |
| ATP5POATP synthase peripheral stalk subunit OSCP | Dažnai (30–79%) | 1 ligoje |
| ATPAF2ATP synthase mitochondrial F1 complex assembly factor 2 | Dažnai (30–79%) | 1 ligoje |
| BAG3BAG cochaperone 3 | Dažnai (30–79%) | 1 ligoje |
| BAG5BAG cochaperone 5 | Dažnai (30–79%) | 1 ligoje |
| BMP2bone morphogenetic protein 2 | Dažnai (30–79%) | 2 ligose |
| CAP2cyclase associated actin cytoskeleton regulatory protein 2 | Dažnai (30–79%) | 1 ligoje |
| CASRcalcium sensing receptor | Dažnai (30–79%) | 1 ligoje |
| CBLCbl proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| COX7Bcytochrome c oxidase subunit 7B | Dažnai (30–79%) | 2 ligose |
| CPT2carnitine palmitoyltransferase 2 | Dažnai (30–79%) | 3 ligose |
| CRYABcrystallin alpha B | Dažnai (30–79%) | 1 ligoje |
| CSRP3cysteine and glycine rich protein 3 | Dažnai (30–79%) | 1 ligoje |
| DESdesmin | Dažnai (30–79%) | 1 ligoje |
Rodyti dar 199 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| DMDdystrophin | Dažnai (30–79%) | 3 ligose |
| DOLKdolichol kinase | Dažnai (30–79%) | 2 ligose |
| DSG2desmoglein 2 | Dažnai (30–79%) | 1 ligoje |
| DSPdesmoplakin | Dažnai (30–79%) | 1 ligoje |
| FHL2four and a half LIM domains 2 | Dažnai (30–79%) | 1 ligoje |
| FKTNfukutin | Dažnai (30–79%) | 1 ligoje |
| FLNCfilamin C | Dažnai (30–79%) | 1 ligoje |
| GATAD1GATA zinc finger domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GDAP1ganglioside induced differentiation associated protein 1 | Dažnai (30–79%) | 1 ligoje |
| GET3guided entry of tail-anchored proteins factor 3, ATPase | Dažnai (30–79%) | 1 ligoje |
| GNA11G protein subunit alpha 11 | Dažnai (30–79%) | 1 ligoje |
| GNB5G protein subunit beta 5 | Dažnai (30–79%) | 1 ligoje |
| GSNgelsolin | Dažnai (30–79%) | 1 ligoje |
| GYG1glycogenin 1 | Dažnai (30–79%) | 1 ligoje |
| HAND2heart and neural crest derivatives expressed 2 | Dažnai (30–79%) | 1 ligoje |
| HCCSholocytochrome c synthase | Dažnai (30–79%) | 2 ligose |
| JPH2junctophilin 2 | Dažnai (30–79%) | 1 ligoje |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Dažnai (30–79%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| LAMA4laminin subunit alpha 4 | Dažnai (30–79%) | 1 ligoje |
| LDB3LIM domain binding 3 | Dažnai (30–79%) | 1 ligoje |
| LEMD2LEM domain nuclear envelope protein 2 | Dažnai (30–79%) | 1 ligoje |
| LMOD2leiomodin 2 | Dažnai (30–79%) | 1 ligoje |
| LZTR1leucine zipper like post translational regulator 1 | Dažnai (30–79%) | 1 ligoje |
| MRASmuscle RAS oncogene homolog | Dažnai (30–79%) | 1 ligoje |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Dažnai (30–79%) | 3 ligose |
| MT-ATP8mitochondrially encoded ATP synthase membrane subunit 8 | Dažnai (30–79%) | 1 ligoje |
| MYBPC3myosin binding protein C3 | Dažnai (30–79%) | 1 ligoje |
| MYH6myosin heavy chain 6 | Dažnai (30–79%) | 3 ligose |
| MYH7myosin heavy chain 7 | Dažnai (30–79%) | 3 ligose |
| MYPNmyopalladin | Dažnai (30–79%) | 1 ligoje |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Dažnai (30–79%) | 2 ligose |
| NEXNnexilin F-actin binding protein | Dažnai (30–79%) | 1 ligoje |
| NPPAnatriuretic peptide A | Dažnai (30–79%) | 1 ligoje |
| NRAPnebulin related anchoring protein | Dažnai (30–79%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| PCCApropionyl-CoA carboxylase subunit alpha | Dažnai (30–79%) | 1 ligoje |
| PCCBpropionyl-CoA carboxylase subunit beta | Dažnai (30–79%) | 1 ligoje |
| PEX1peroxisomal biogenesis factor 1 | Dažnai (30–79%) | 2 ligose |
| PEX6peroxisomal biogenesis factor 6 | Dažnai (30–79%) | 2 ligose |
| PLNphospholamban | Dažnai (30–79%) | 1 ligoje |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Dažnai (30–79%) | 1 ligoje |
| PPCSphosphopantothenoylcysteine synthetase | Dažnai (30–79%) | 1 ligoje |
| PRDM16PR/SET domain 16 | Dažnai (30–79%) | 2 ligose |
| PSEN1presenilin 1 | Dažnai (30–79%) | 1 ligoje |
| PSEN2presenilin 2 | Dažnai (30–79%) | 1 ligoje |
| PSMB8proteasome 20S subunit beta 8 | Dažnai (30–79%) | 1 ligoje |
| RASA2RAS p21 protein activator 2 | Dažnai (30–79%) | 1 ligoje |
| RBM20RNA binding motif protein 20 | Dažnai (30–79%) | 1 ligoje |
| RIT1Ras like without CAAX 1 | Dažnai (30–79%) | 1 ligoje |
| RPL3Lribosomal protein L3 like | Dažnai (30–79%) | 1 ligoje |
| RRASRAS related | Dažnai (30–79%) | 1 ligoje |
| RRAS2RAS related 2 | Dažnai (30–79%) | 1 ligoje |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Dažnai (30–79%) | 1 ligoje |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Dažnai (30–79%) | 3 ligose |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Dažnai (30–79%) | 2 ligose |
| SGCDsarcoglycan delta | Dažnai (30–79%) | 1 ligoje |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Dažnai (30–79%) | 1 ligoje |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Dažnai (30–79%) | 1 ligoje |
| SPRED2sprouty related EVH1 domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| TAF1ATATA-box binding protein associated factor, RNA polymerase I subunit A | Dažnai (30–79%) | 1 ligoje |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Dažnai (30–79%) | 3 ligose |
| TANGO2transport and golgi organization 2 homolog | Dažnai (30–79%) | 1 ligoje |
| TCAPtitin-cap | Dažnai (30–79%) | 1 ligoje |
| TMPOthymopoietin | Dažnai (30–79%) | 1 ligoje |
| TNNC1troponin C1, slow skeletal and cardiac type | Dažnai (30–79%) | 1 ligoje |
| TNNI3troponin I3, cardiac type | Dažnai (30–79%) | 1 ligoje |
| TNNT2troponin T2, cardiac type | Dažnai (30–79%) | 1 ligoje |
| TPM1tropomyosin 1 | Dažnai (30–79%) | 1 ligoje |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Dažnai (30–79%) | 2 ligose |
| TTRtransthyretin | Dažnai (30–79%) | 2 ligose |
| TXNRD2thioredoxin reductase 2 | Dažnai (30–79%) | 1 ligoje |
| VCLvinculin | Dažnai (30–79%) | 1 ligoje |
| VEZF1vascular endothelial zinc finger 1 | Dažnai (30–79%) | 1 ligoje |
| WASWASP actin nucleation promoting factor | Dažnai (30–79%) | 1 ligoje |
| ACADMacyl-CoA dehydrogenase medium chain | Kartais (5–29%) | 1 ligoje |
| AIPAHR interacting HSP90 co-chaperone | Kartais (5–29%) | 1 ligoje |
| ALDOAaldolase, fructose-bisphosphate A | Kartais (5–29%) | 1 ligoje |
| ASLargininosuccinate lyase | Kartais (5–29%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Kartais (5–29%) | 1 ligoje |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Kartais (5–29%) | 1 ligoje |
| CCND1cyclin D1 | Kartais (5–29%) | 1 ligoje |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Kartais (5–29%) | 1 ligoje |
| COL4A1collagen type IV alpha 1 chain | Kartais (5–29%) | 1 ligoje |
| CPT1Acarnitine palmitoyltransferase 1A | Kartais (5–29%) | 2 ligose |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Kartais (5–29%) | 1 ligoje |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Kartais (5–29%) | 1 ligoje |
| FBXL4F-box and leucine rich repeat protein 4 | Kartais (5–29%) | 1 ligoje |
| FHL1four and a half LIM domains 1 | Kartais (5–29%) | 1 ligoje |
| FOXC2forkhead box C2 | Kartais (5–29%) | 2 ligose |
| GATA4GATA binding protein 4 | Kartais (5–29%) | 1 ligoje |
| GATA6GATA binding protein 6 | Kartais (5–29%) | 1 ligoje |
| GJA1gap junction protein alpha 1 | Kartais (5–29%) | 2 ligose |
| GLAgalactosidase alpha | Kartais (5–29%) | 2 ligose |
| GNAQG protein subunit alpha q | Kartais (5–29%) | 1 ligoje |
| GPR101G protein-coupled receptor 101 | Kartais (5–29%) | 1 ligoje |
| GTPBP3GTP binding protein 3, mitochondrial | Kartais (5–29%) | 1 ligoje |
| HADHAhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Kartais (5–29%) | 2 ligose |
| HADHBhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | Kartais (5–29%) | 1 ligoje |
| HDAC4histone deacetylase 4 | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 2 ligose |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 2 ligose |
| HSPG2heparan sulfate proteoglycan 2 | Kartais (5–29%) | 1 ligoje |
| KCNE3potassium voltage-gated channel subfamily E regulatory subunit 3 | Kartais (5–29%) | 1 ligoje |
| LAMA2laminin subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| LPIN1lipin 1 | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 1 ligoje |
| MGAT2alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Kartais (5–29%) | 1 ligoje |
| MGME1mitochondrial genome maintenance exonuclease 1 | Kartais (5–29%) | 2 ligose |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Kartais (5–29%) | 3 ligose |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Kartais (5–29%) | 4 ligose |
| MT-CYBmitochondrially encoded cytochrome b | Kartais (5–29%) | 3 ligose |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Kartais (5–29%) | 3 ligose |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Kartais (5–29%) | 2 ligose |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Kartais (5–29%) | 2 ligose |
| MT-ND4Lmitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L | Kartais (5–29%) | 2 ligose |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Kartais (5–29%) | 3 ligose |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Kartais (5–29%) | 3 ligose |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Kartais (5–29%) | 2 ligose |
| NDUFS2NADH:ubiquinone oxidoreductase core subunit S2 | Kartais (5–29%) | 1 ligoje |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Kartais (5–29%) | 1 ligoje |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Kartais (5–29%) | 1 ligoje |
| PEX10peroxisomal biogenesis factor 10 | Kartais (5–29%) | 1 ligoje |
| PEX11Bperoxisomal biogenesis factor 11 beta | Kartais (5–29%) | 1 ligoje |
| PEX12peroxisomal biogenesis factor 12 | Kartais (5–29%) | 1 ligoje |
| PEX13peroxisomal biogenesis factor 13 | Kartais (5–29%) | 1 ligoje |
| PEX14peroxisomal biogenesis factor 14 | Kartais (5–29%) | 1 ligoje |
| PEX16peroxisomal biogenesis factor 16 | Kartais (5–29%) | 1 ligoje |
| PEX19peroxisomal biogenesis factor 19 | Kartais (5–29%) | 1 ligoje |
| PEX2peroxisomal biogenesis factor 2 | Kartais (5–29%) | 1 ligoje |
| PEX26peroxisomal biogenesis factor 26 | Kartais (5–29%) | 1 ligoje |
| PEX3peroxisomal biogenesis factor 3 | Kartais (5–29%) | 1 ligoje |
| PEX5peroxisomal biogenesis factor 5 | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Kartais (5–29%) | 1 ligoje |
| POLG2DNA polymerase gamma 2, accessory subunit | Kartais (5–29%) | 2 ligose |
| PRTN3proteinase 3 | Kartais (5–29%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Kartais (5–29%) | 2 ligose |
| RAI1retinoic acid induced 1 | Kartais (5–29%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Kartais (5–29%) | 1 ligoje |
| SALL4spalt like transcription factor 4 | Kartais (5–29%) | 1 ligoje |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Kartais (5–29%) | 2 ligose |
| SCUBE3signal peptide, CUB domain and EGF like domain containing 3 | Kartais (5–29%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Kartais (5–29%) | 1 ligoje |
| SDHCsuccinate dehydrogenase complex subunit C | Kartais (5–29%) | 1 ligoje |
| SLC25A4solute carrier family 25 member 4 | Kartais (5–29%) | 1 ligoje |
| SLC40A1solute carrier family 40 member 1 | Kartais (5–29%) | 1 ligoje |
| SOX10SRY-box transcription factor 10 | Kartais (5–29%) | 1 ligoje |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Kartais (5–29%) | 1 ligoje |
| TBX20T-box transcription factor 20 | Kartais (5–29%) | 1 ligoje |
| TBX3T-box transcription factor 3 | Kartais (5–29%) | 2 ligose |
| TLL1tolloid like 1 | Kartais (5–29%) | 1 ligoje |
| TMEM70transmembrane protein 70 | Kartais (5–29%) | 2 ligose |
| TTPAalpha tocopherol transfer protein | Kartais (5–29%) | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Kartais (5–29%) | 2 ligose |
| VHLvon Hippel-Lindau tumor suppressor | Kartais (5–29%) | 1 ligoje |
| ACADVLacyl-CoA dehydrogenase very long chain | Retai (1–4 %) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Retai (1–4 %) | 1 ligoje |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Retai (1–4 %) | 1 ligoje |
| BMP6bone morphogenetic protein 6 | Retai (1–4 %) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Retai (1–4 %) | 1 ligoje |
| CLCN1chloride voltage-gated channel 1 | Retai (1–4 %) | 1 ligoje |
| HBBhemoglobin subunit beta | Retai (1–4 %) | 2 ligose |
| HFEhomeostatic iron regulator | Retai (1–4 %) | 2 ligose |
| HRASHRas proto-oncogene, GTPase | Retai (1–4 %) | 2 ligose |
| IVDisovaleryl-CoA dehydrogenase | Retai (1–4 %) | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Retai (1–4 %) | 2 ligose |
| RHOBTB2Rho related BTB domain containing 2 | Retai (1–4 %) | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Retai (1–4 %) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Retai (1–4 %) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Retai (1–4 %) | 1 ligoje |
| CAV3caveolin 3 | Neužfiksuota | 1 ligoje |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Neužfiksuota | 1 ligoje |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Neužfiksuota | 1 ligoje |
| ETFAelectron transfer flavoprotein subunit alpha | Neužfiksuota | 1 ligoje |
| ETFBelectron transfer flavoprotein subunit beta | Neužfiksuota | 1 ligoje |
| ETFDHelectron transfer flavoprotein dehydrogenase | Neužfiksuota | 1 ligoje |
| GPC3glypican 3 | Neužfiksuota | 1 ligoje |
| HJVhemojuvelin BMP co-receptor | Neužfiksuota | 1 ligoje |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Neužfiksuota | 1 ligoje |
| MT-TCmitochondrially encoded tRNA-Cys (UGU/C) | Neužfiksuota | 1 ligoje |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Neužfiksuota | 1 ligoje |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Neužfiksuota | 1 ligoje |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Neužfiksuota | 1 ligoje |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Neužfiksuota | 1 ligoje |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Neužfiksuota | 1 ligoje |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Neužfiksuota | 1 ligoje |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Neužfiksuota | 1 ligoje |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Neužfiksuota | 1 ligoje |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Neužfiksuota | 1 ligoje |
| PEX7peroxisomal biogenesis factor 7 | Neužfiksuota | 1 ligoje |
| PHYHphytanoyl-CoA 2-hydroxylase | Neužfiksuota | 1 ligoje |
| SLC19A2solute carrier family 19 member 2 | Neužfiksuota | 1 ligoje |
| SYNE2spectrin repeat containing nuclear envelope protein 2 | Neužfiksuota | 1 ligoje |
| TDP2tyrosyl-DNA phosphodiesterase 2 | Neužfiksuota | 1 ligoje |
| WIPI2WD repeat domain, phosphoinositide interacting 2 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites